W. Mark Watson

W. Mark Watson (senior executive) discloses dealings in 3 companies, chiefly Vaxart, Inc., Biodelivery Sciences International Inc and Sykes Enterprises Inc. We count 14 filings; the first trade dates from 19 May 2021 and the latest from 16 July 2026.

The open-market record is one-sided, with 4 purchases worth €36k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants and 2 option exercises.

Half of the purchases are above €8,967 and half below. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 17 July 2026: a share grant, in Vaxart, Inc. The last insider purchase was made public on 5 December 2025, 317 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.